Skip to content
Skindermlab
EN
PLLA-Based Collagen Stimulator - Biostimulators product
Biostimulators

PLLA-Based Collagen Stimulator

The category's most established active ingredient: a biodegradable poly-L-lactic acid (PLLA) formulation that triggers a controlled tissue response so the body builds its own collagen over time.

PLLA has the longest clinical track record in the biostimulator market. Rather than delivering immediate volume, it triggers a controlled inflammatory response in the tissue that supports the body's own collagen production over time. A synthetic polymer long used safely in dissolvable surgical sutures, it's considered a pioneer of the 2026 biostimulator trend summed up as "regeneration over replacement." This gradual mechanism is favored in protocols aiming for a natural, progressively-building result. Microparticle size, suspension concentration, and vial content are set specifically to your brand; supplied in sterile lyophilized powder or ready-to-use suspension format, ready for production.

  • Gradual collagen production via a controlled tissue response
  • The category's longest-standing clinical track record
  • Suited to protocols targeting a natural, progressive result
  • A polymer with proven safety, also used in dissolvable surgical sutures
  • Custom microparticle size and concentration options under your brand
  • Sterile lyophilized powder or ready-to-use suspension format

Want to manufacture under your own brand?

Manufactured to GMP standards, delivered with an MSDS. Certifications

Key Ingredients

Poly-L-Lactic Acid (PLLA) Microparticles

Trigger a controlled inflammatory response in tissue, gradually increasing the body's own collagen production.

Carboxymethylcellulose (CMC) / Sodium CMC Carrier

Enables the lyophilized powder to be reconstituted into a homogeneous suspension.

Related Ingredients

How to Use

  1. 1Reconstituted with sterile water into a suspension before use (or delivered as a ready-to-use suspension).
  2. 2Applied to the target area via deep dermal/subcutaneous injection technique.
  3. 3Collagen production begins gradually; a course of 2-4 sessions, 4-6 weeks apart, is typically recommended.
  4. 4Results are expected to last around 18-24 months, with maintenance planned around this cycle.

Frequently Asked Questions

What sets PLLA apart from your CaHA or PCL-based products?

PLLA has the longest clinical track record and the most published data in the category; it works entirely through a gradual mechanism with no immediate volume effect. CaHA also delivers immediate volume, while PLLA and PCL are favored in protocols targeting a natural, progressive result.

Do you supply lyophilized powder or ready-to-use suspension?

We offer both; lyophilized powder offers a shelf-life advantage, while ready-to-use suspension speeds up clinical workflow. We can recommend based on your brand strategy.

Can microparticle size and concentration be customized for my brand?

Yes, microparticle size and suspension concentration can be tiered based on the target area and your clinical protocol.

How is safety and quality documentation handled?

Production takes place under GMP-standard sterile conditions; we deliver product registration, MSDS reports, and biocompatibility certificates along with production.

Similar Products